| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_352a136540ef4fbf0fc07ad364efa67c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 |
| filingDate |
1991-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5b337e6240afa9a8d050e507e020aec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d46c6f79f79f59df58afb74c82e78735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e35de07627098374cd55a9d6bfaa21e9 |
| publicationDate |
1998-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0532546-B1 |
| titleOfInvention |
A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols |
| abstract |
A method for administering a therapeutically effective amount of a biologically active substance to the circulatory system of a mammal including administering a pharmaceutical composition having a total volume of 1-1000 mu 1 to a nasal mucosal membrane of the mammal, the pharmaceutical composition including the therapeutically effective amount of the biologically active substance dissolved or suspended in a volume of 1-1000 mu 1 of a n-glycofurol-containing vehicle including at least one n-glycofurol represented by the formula: <IMAGE> wherein n is from 1 to 8, so that upon administration of the pharmaceutical composition to the nasal mucosal membrane, absorption of the biologically active substance through the mucosal membrane and into the blood stream of the mammal rapidly takes place and thereby allows the biologically active substance to exert its therapeutic effect. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8592406-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11712475-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11110093-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004110403-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9962392-B2 |
| priorityDate |
1990-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |